A. Tagnon

Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study.

M. Piccart-Gebhart, M. Paesmans, E. de Azambuja, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.

M. Piccart, M. Paesmans, C. Focan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antilymphocyte globulin and renal transplantation.

A. Tagnon, 1976, Postgraduate medical journal.

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer

M. Paesmans, J. Sculier, F. Ries, 1994 .

Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group study.

M. Buyse, B. Vanderlinden, N. Duez, 1990, Cancer investigation.

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial

E. Salamon, C. Focan, M. Beauduin, 2001, British Journal of Cancer.

Combination Chemotherapy with Ifosfamide and Nimustine (IMA) as Salvage Treatment for Small Cell Lung Cancer

M. Paesmans, J. Sculier, J. Klastersky, 1993 .

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.

M. Paesmans, J. Sculier, F. Ries, 1994, Lung cancer.

Combination Chemotherapy with Ifosfamide and Nimustine (IMA) as Salvage Treatment for Small Cell Lung Cancer

M. Paesmans, J. Sculier, J. Klastersky, 1993 .